Hrt Financial LP Rhythm Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$21.39 - $49.64 $85,174 - $197,666	3,982 Added 7.88%	54,534 $2.51 Million
Q3 2023 Nov 13, 2023	BUY	$15.81 - $27.8 $799,227 - $1.41 Million	50,552 New	50,552 $1.16 Million
Q1 2023 May 12, 2023	BUY	$16.88 - $34.24 $3.69 Million - $7.48 Million	218,445 New	218,445 $3.9 Million
Q2 2022 Aug 12, 2022	SELL	$3.12 - $12.25 $153,497 - $602,675	-49,198 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.13 - $12.24 $142,706 - $284,947	23,280 Added 89.82%	49,198 $566,000
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $223,413 - $360,260	25,918 New	25,918 $258,000

191

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.